Tokumoto M - Search Results

1

Phase 2 study of upacicalcet in Japanese haemodialysis patients with secondary hyperparathyroidism: an intraindividual dose-adjustment study.

Inaguma D, Koiwa F, Tokumoto M, Fukagawa M, Yoneda S, Yasuzawa H, Asano K, Hagita K, Inagaki Y, Honda D, Akizawa T. Inaguma D, et al. Among authors: tokumoto m. Clin Kidney J. 2023 Sep 4;16(12):2614-2625. doi: 10.1093/ckj/sfad213. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38045997 Free PMC article.

2

[The pathophysiology of secondary hyperparathyroidism].

Tokumoto M. Tokumoto M. Clin Calcium. 2016 Jun;26(6):821-9. Clin Calcium. 2016. PMID: 27230837 Review. Japanese.

3

Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio.

Yamada S, Tokumoto M, Taniguchi M, Kitada H, Tsuruya K, Kitazono T. Yamada S, et al. Among authors: tokumoto m. Clin Kidney J. 2013 Aug;6(4):429-32. doi: 10.1093/ckj/sft061. Clin Kidney J. 2013. PMID: 27293572 Free PMC article.

4

Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism.

Tokumoto M, Tokunaga S, Asada S, Endo Y, Kurita N, Fukagawa M, Akizawa T. Tokumoto M, et al. PLoS One. 2022 Dec 13;17(12):e0279078. doi: 10.1371/journal.pone.0279078. eCollection 2022. PLoS One. 2022. PMID: 36512619 Free PMC article. Clinical Trial.

5

Persistent hyperparathyroidism in renal allograft recipients: vitamin D receptor, calcium-sensing receptor, and apoptosis.

Taniguchi M, Tokumoto M, Matsuo D, Motoyama K, Sugitani A, Kuroki S, Yotsueda H, Tsuruya K, Hirakata H, Iida M. Taniguchi M, et al. Among authors: tokumoto m. Kidney Int. 2006 Jul;70(2):363-70. doi: 10.1038/sj.ki.5001549. Epub 2006 May 31. Kidney Int. 2006. PMID: 16738533 Free article.

6

Short- and Long-term Effects of Dialysate Calcium Concentrations on Mineral and Bone Metabolism in Hemodialysis Patients: The K4 Study.

Sakoh T, Taniguchi M, Yamada S, Ohnaka S, Arase H, Tokumoto M, Yanagida T, Mitsuiki K, Hirakata H, Nakano T, Kitazono T, Tsuruya K. Sakoh T, et al. Among authors: tokumoto m. Kidney Med. 2019 Sep 11;1(5):296-306. doi: 10.1016/j.xkme.2019.08.002. eCollection 2019 Sep-Oct. Kidney Med. 2019. PMID: 32734210 Free PMC article.

7

Malnutrition-Inflammation Complex Syndrome and Bone Fractures and Cardiovascular Disease Events in Patients Undergoing Hemodialysis: The Q-Cohort Study.

Yamada S, Arase H, Yoshida H, Kitamura H, Tokumoto M, Taniguchi M, Hirakata H, Tsuruya K, Nakano T, Kitazono T. Yamada S, et al. Among authors: tokumoto m. Kidney Med. 2022 Jan 10;4(3):100408. doi: 10.1016/j.xkme.2022.100408. eCollection 2022 Mar. Kidney Med. 2022. PMID: 35386605 Free PMC article.

8

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism.

Tokumoto M, Tsuruya K, Fukuda K, Kanai H, Kuroki S, Hirakata H. Tokumoto M, et al. Kidney Int. 2002 Oct;62(4):1196-207. doi: 10.1111/j.1523-1755.2002.kid585.x. Kidney Int. 2002. PMID: 12234290 Free article.

9

[Present status and problems in vitamin D and sevelamer therapy (discussion)].

Tahara H, Yumita S, Ishida M, Tsuruta Y, Cunningham J, Fukagawa M, Tominaga Y, Tokumoto M, Onoda N. Tahara H, et al. Among authors: tokumoto m. Clin Calcium. 2005 Sep;15 Suppl 1:225-8. Clin Calcium. 2005. PMID: 16279028 Japanese. No abstract available.

10

Parathyroid growth and regression in experimental uremia.

Taniguchi M, Tokumoto M, Matsuo D, Tsuruya K, Hirakata H, Iida M. Taniguchi M, et al. Among authors: tokumoto m. Kidney Int. 2006 Feb;69(3):464-70. doi: 10.1038/sj.ki.5000090. Kidney Int. 2006. PMID: 16395258 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters